Evidence map›Paper›PMID 34480131›Full record

ReviewNature protocols2021

Mass cytometry profiling of human dendritic cells in blood and tissues.

Marcela Alcántara-Hernández, Juliana Idoyaga

Open access · greenAbstract readReview
In one paragraph

Review in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Monocytes give rise to Langerhans cells that preferentially migrate to lymph nodes at steady state.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marcela Alcántara-HernándezMicrobiology & Immunology Department and Immunology Program, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3620-1248
Juliana IdoyagaMicrobiology & Immunology Department and Immunology Program, Stanford University School of Medicine, Stanford, CA, USA. jidoyaga@stanford.edu.ORCID http://orcid.org/0000-0002-4430-8862
Stanford University · US

Funding

Transitional dendritic cells: identifying the origin and role of a novel innate immune population during viral infectionR01AI158808 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Juliana Idoyaga · 2021 to 2026
$3.5M
Harnessing human dendritic cell subsets for the design of novel immunotherapiesDP2AR069953 · NIAMS · STANFORD UNIVERSITY · PI IDOYAGA, JULIANA · 2015 to 2015
$2.4M
Effect of radiotherapy on dendritic cell subsets: implications for immunotherapyR01CA219994 · NCI · STANFORD UNIVERSITY · PI IDOYAGA, JULIANA · 2017 to 2021
$1.6M
CyTOFS10OD016318 · OD · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2013 to 2013
$600k
Novel transcription factors modulating the development and function of pDCs and pDC-related cellsR21AI163775 · NIAID · STANFORD UNIVERSITY · PI IDOYAGA, JULIANA · 2021 to 2022
$437k
NCI NIH HHS R01 CA219994NIAID NIH HHS R01 AI158808NIAID NIH HHS R21 AI163775NIAMS NIH HHS DP2 AR069953NIH HHS S10 OD016318
6 · The paper itself

Abstract

The immune system comprises distinct functionally specialized cell populations, which can be characterized in depth by mass cytometry protein profiling. Unfortunately, the low-throughput nature of mass cytometry has made it challenging to analyze minor cell populations. This is the case for dendritic cells, which represent 0.2-2% of all immune cells in tissues and yet perform the critical task of initiating and modulating immune responses. Here, we provide an optimized step-by-step protocol for the characterization of well-known and emerging human dendritic cell populations in blood and tissues using mass cytometry. We provide detailed instructions for the generation of single-cell suspensions, sample enrichment, staining, acquisition and data analysis. We also include a barcoding option that reduces acquisition variability and allows the analysis of low numbers of dendritic cells, i.e., ~20,000. In contrast to other protocols, we emphasize the use of negative selection approaches to enrich for minor populations of immune cells while avoiding their activation. The entire procedure can be completed in 2-3 d and can be conveniently paused at several stages. The procedure described in this robust and reliable protocol allows the analysis of human dendritic cells in health and disease and during vaccination.

Indexed as

Dendritic CellsFlow CytometryHumansSingle-Cell Analysis

Identifiers

PMID34480131
PMCPMC10538357
OpenAlexW3198637920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.